SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Oslo, Norway Cancer Registry. Cancer in Norway 2001. Oslo: Institute of Epidemiologic Cancer Research, 2004.
  • 2
    Shoker BS, Sloane JP. DCIS grading schemes and clinical implications. Histopathology. 1999; 35: 393400.
    Direct Link:
  • 3
    Silverstein MJ, Poller DN, Waisman J, et al. Prognostic classification of breast ductal carcinoma-in situ. Lancet. 1995; 345: 11541157.
  • 4
    Lilleng R, Hagmar B. The comedo subtype of intraductal carcinoma. Cytologic characteristics. Acta Cytol. 1992; 36: 345352.
  • 5
    Lilleng R, Hagmar B, Farrants G. Low-grade cribriform ductal carcinoma in situ of the breast. Acta Cytol. 1992; 36(1): 4854.
  • 6
    Malamud YR, Ducatman BS, Wang HH. Comparative features of comedo and noncomedo ductal carcinoma in situ of the breast on fine-needle aspiration biopsy. Diagn Cytopathol. 1992; 8(6): 571576.
  • 7
    Bonzanini M, Gilioli E, Brancato B, et al. The cytopathology of ductal carcinoma in situ of the breast. A detailed analysis of fine needle aspiration cytology of 58 cases compared with 101 invasive ductal carcinomas. Cytopathology. 2001; 12: 107119.
  • 8
    Lindholm K. Breast. In: OrellSR, SterrettGF, WaltersMN-I, WhitakerD, editors. Manual and atlas of fine needle aspiration cytology. London: Churchill Livingstone, 1999: 172181.
  • 9
    McKee G, Tambouret RH, Finkelstein D. Fine-needle aspiration cytology of the breast: invasive vs. in situ carcinoma. Diagn Cytopathol. 2001; 25(1): 7377.
  • 10
    Sauer T, Young K, Thoresen SØ. Fine needle aspiration cytology in the work-up of mammographic and ultrasonographic findings in breast cancer screening: an attempt at differentiating in situ and invasive carcinoma. Cytopathology. 2002; 13(2): 101110.
  • 11
    Sauer T, Myrvold K, Lømo J, Anderssen KY, Skanne P. Fine-needle aspiration cytology in non-palpable mammographic abnormalities in breast cancer screening: results from the breast cancer screening programme in Oslo 1996-2001. Breast. 2003; 12: 314319.
  • 12
    Shin HJ, Sneige N. Is a diagnosis of infiltrating versus in situ ductal carcinoma of the breast possible in fine-needle aspiration specimens? Cancer (Cancer Cytopathol). 1998; 84: 186191.
  • 13
    Silverman JF, Masood S, Ducatman BS, Wang HH, Sneige N. Can FNA biopsy separate atypical hyperplasia, carcinoma in situ, and invasive carcinoma of the breast? Diagn Cytopathol. 1993; 9: 713728.
  • 14
    Venegas R, Ritgers JL, Cameron BL, Vargas H, Butler JA. Fine needle aspiration cytology of breast ductal carcinoma in situ. Acta Cytol. 1994; 38: 136143.
  • 15
    Wang HH, Ducatman BS, Eick D. Comparative features of ductal carcinoma in situ and infiltrating ductal carcinoma of the breast on fine-needle aspiration biopsy. Am J Clin Pathol. 1989; 92: 736740.
  • 16
    Cangiarella J, Waisman J, Simsir A. Cytologic findings with histologic correlation in 43 cases of mammary intraductal adenocarcinoma diagnosed by aspiration biopsy. Acta Cytol. 2003; 47: 965972.
  • 17
    Klijanienko J, Katsahian S, Vielh P, Masood S. Stromal infiltration as a predictor of tumor invasion in breast fine-needle aspiration biopsy. Diagn Cytopathol. 2004; 30(3): 182186.
  • 18
    Kumarasinghe MP, Poh WT. Differentiating nonhigh-grade duct carcinoma in situ from benign breast lesions. Diagn Cytopathol. 2004; 30: 98102.
  • 19
    Tavassoli FA, Hoefler H, Rosai J, et al. Intraductal proliferative lesions. In: FattanehA, TavassoliA, DevileeP, editors. Tumours of the breast and female genital organs. Lyon: Oxford University Press, 2002: 6373.
  • 20
    Kåresen R, Jensen HH, Sauer T, Schlichting E, Skaane P, Wang HH. Logistics of referral, diagnostic assessment and treatment of patients with breast symptoms and signs. Scand J Surg. 2002; 91: 232238.
  • 21
    McKee GT, Tildsley G, Hammond S. Cytologic diagnosis and grading of ductal carcinoma in situ. Cancer (Cancer Cytopathol). 1999; 87(4): 203209.
  • 22
    Grading of invasive carcinoma of the breast. In: ElstonCW, editor. Diagnostic histopathology of the breast. Edinburgh: Churchill-Livingstone, 1987: 300312.
  • 23
    Bloom H, Richardson W. Histological grading and prognosis in breast cancer. Br J Cancer. 1957; 11: 359377.
  • 24
    Bondeson L, Lindholm K. Prediction of invasiveness by aspiration cytology applied to nonpalpable breast carcinoma and tested in 300 cases. Diagn Cytopathol. 1997; 17(5): 315320.
  • 25
    Frost AR, Tabbara SO, Poprocky LA, Weiss H, Sidawy MK. Cytologic features of proliferative breast disease. A study designed to minimize sampling error. Cancer (Cancer Cytopathol). 2000; 90(1): 3340.
  • 26
    Sidawy MK, Tabbara SO, Bryan JA, Poprocky LA, Frost AR. The spectrum of cytologic features in nonproliferative breast lesions. Cancer (Cancer Cytopathol). 2001; 93(2): 140145.
  • 27
    Simsir A, Waisman J, Thorner K, Cangiarella J. Mammary lesions diagnosed as “papillary” by aspiration biopsy. Cancer (Cancer Cytopathol). 2003; 99(3): 156165.